| |  Online-Ressource |
|---|
| Verfasst von: | Betge, Johannes [VerfasserIn]  |
|---|
| | Chi-Kern, Jing [VerfasserIn] |
|---|
| | Schulte, Nadine [VerfasserIn] |
|---|
| | Belle, Sebastian [VerfasserIn] |
|---|
| | Gutting, Tobias [VerfasserIn] |
|---|
| | Burgermeister, Elke [VerfasserIn] |
|---|
| | Jesenofsky, Ralf [VerfasserIn] |
|---|
| | Ebert, Matthias [VerfasserIn] |
|---|
| | Härtel, Nicolai [VerfasserIn] |
|---|
| Titel: | A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) |
|---|
| Verf.angabe: | Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert and Nicolai Haertel |
|---|
| E-Jahr: | 2018 |
|---|
| Jahr: | 18 July 2018 |
|---|
| Fussnoten: | Gesehen am 04.09.2018 |
|---|
| Titel Quelle: | Enthalten in: BMC cancer |
|---|
| Ort Quelle: | London : BioMed Central, 2001 |
|---|
| Jahr Quelle: | 2018 |
|---|
| Band/Heft Quelle: | 18(2018) Artikel-Nummer 747, 7 Seiten |
|---|
| ISSN Quelle: | 1471-2407 |
|---|
| Abstract: | In the group of elderly patients (≥70 years) with metastatic pancreatic ductal adenocarcinoma (mPDAC), it is not known who benefits from intensive 1st line nab-paclitaxel/gemcitabine (nab-p/gem) combination chemotherapy or who would rather suffer from increased toxicity. We aim to determine whether treatment individualization by comprehensive geriatric assessments (CGAs) improves functional outcome of the patients. |
|---|
| DOI: | doi:10.1186/s12885-018-4665-2 |
|---|
| URL: | kostenfrei: Volltext: http://dx.doi.org/10.1186/s12885-018-4665-2 |
|---|
| | kostenfrei: Volltext: https://doi.org/10.1186/s12885-018-4665-2 |
|---|
| | DOI: https://doi.org/10.1186/s12885-018-4665-2 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1580646735 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
¬A¬ multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) / Betge, Johannes [VerfasserIn]; 18 July 2018 (Online-Ressource)
